Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group
Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA
JAMA 1998 Mar 18;279(11):839-846
clinical trial
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

CONTEXT: Nonpharmacologic interventions are frequently recommended for treatment of hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials in support of this recommendation. OBJECTIVE: To determine whether weight loss or reduced sodium intake is effective in the treatment of older persons with hypertension. DESIGN: Randomized controlled trial. PARTICIPANTS: A total of 975 (corrected) men and women aged 60 to 80 years with systolic blood pressure lower than 145 mmHg and diastolic blood pressure lower than 85 mmHg while receiving treatment with a single antihypertensive medication. SETTING: Four academic health centers. INTERVENTION: The 585 obese participants were randomized to reduced sodium intake, weight loss, both, or usual care, and the 390 nonobese participants were randomized to reduced sodium intake or usual care. Withdrawal of antihypertensive medication was attempted after 3 months of intervention. MAIN OUTCOME MEASURE: Diagnosis of high blood pressure at 1 or more follow-up visits, or treatment with antihypertensive medication, or a cardiovascular event during follow-up (range 15 to 36 months; median 29 months). RESULTS: The combined outcome measure was less frequent among those assigned versus not assigned to reduced sodium intake (relative hazard ratio 0.69; 95% confidence interval (CI) 0.59 to 0.81; p < 0.001) and, in obese participants, among those assigned versus not assigned to weight loss (relative hazard ratio 0.70; 95% CI 0.57 to 0.87; p < 0.001). Relative to usual care, hazard ratios among the obese participants were 0.60 (95% CI 0.45 to 0.80; p < 0.001) for reduced sodium intake alone, 0.64 (95% CI 0.49 to 0.85; p = 0.002) for weight loss alone, and 0.47 (95% CI 0.35 to 0.64; p < 0.001) for reduced sodium intake and weight loss combined. The frequency of cardiovascular events during follow-up was similar in each of the 6 treatment groups. CONCLUSION: Reduced sodium intake and weight loss constitute a feasible, effective, and safe nonpharmacologic therapy of hypertension in older persons.

Full text (sometimes free) may be available at these link(s):      help